Mark your calendars for a workshop jointly sponsored by the Food and Drug
Administration (FDA) and the University of Maryland Center of Excellence in
Regulatory Science and Innovation (M-CERSI).
Drug Development in Pediatric Heart Failure: Extrapolation, Clinical Trial
Design and Endpoints
Friday, October 27, 2017
The workshop will address challenges related to evaluation of products in
pediatric heart failure including population to study, endpoints, and
extrapolation of adult efficacy data. The workshop will also provide a forum
for discussion on the use of registry data as well as alternative trial designs
and statistical methods.
Location/time: FDA's White Oak Campus, located at 10903 New Hampshire Avenue
in Silver Spring, MD, from 8:00 a.m. to 5:00 p.m.
Registration is required to attend.
For the workshop agenda and registration information, please use the link below:
https://oct27workshop.splashthat.com/
Best,
Lily Mulugeta
[email protected]<mailto:[email protected]>